Butler John P.

Akebia Therapeutics, Inc. · CEO and President

Butler John P. is listed in public filings as director, officer: CEO and President. This Butler John P. insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Akebia Therapeutics, Inc. (AKBA). Investors use Butler John P.'s insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Akebia Therapeutics, Inc.AKBA$4.2M3.4M sharesBuyMar 4, 2026$86.6K69.3k shares$1.25--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Akebia Therapeutics, Inc.AKBA$4.8M3.4M sharesGrant / ExerciseFeb 2, 2026$247.1K175.3k shares$1.41--
Akebia Therapeutics, Inc.AKBA$4.5M3.2M sharesSellFeb 2, 2026$159.7K114.9k shares$1.39--
Akebia Therapeutics, Inc.AKBA$4.6M3.3M sharesSellFeb 2, 2026$133.5K96.1k shares$1.39--
Akebia Therapeutics, Inc.AKBA$4.6M3.3M sharesSellFeb 2, 2026$116.3K83.7k shares$1.39--
Akebia Therapeutics, Inc.AKBA$4.7M3.4M sharesSellFeb 2, 2026$64.9K46.7k shares$1.39--
Akebia Therapeutics, Inc.AKBA$1.6M1.1M sharesGrant / ExerciseJan 30, 2026$1.6M1.1M shares$1.41--
Akebia Therapeutics, Inc.AKBA--3.5M sharesGrant / ExerciseJan 30, 2026Disclosure amount unavailable743k shares----
Akebia Therapeutics, Inc.AKBA$4.7M2.6M sharesSellMar 3, 2025$84.9K46.4k shares$1.83--
Akebia Therapeutics, Inc.AKBA$5.5M2.6M sharesSellFeb 3, 2025$205.8K98k shares$2.10--
Akebia Therapeutics, Inc.AKBA$5.7M2.7M sharesSellFeb 3, 2025$97.2K46.3k shares$2.10--
Akebia Therapeutics, Inc.AKBA$2.4M1.1M sharesGrant / ExerciseJan 31, 2025$2.4M1.1M shares$2.24--
Akebia Therapeutics, Inc.AKBA--350.5k sharesGrant / ExerciseJan 31, 2025Disclosure amount unavailable350.5k shares----
Akebia Therapeutics, Inc.AKBA--2.7M sharesGrant / ExerciseJan 31, 2025Disclosure amount unavailable701k shares----